Data mining in drug discovery /

Lead generation approaches in drug discovery
I whakaputaina: (2010)

Biological drug products : development and strategies /
I whakaputaina: (2013)

Drug discovery handbook
I whakaputaina: (2005)

Analogue-based drug discovery III
I whakaputaina: (2013)

Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)

Virtual ADMET assessment in target selection and maturation
I whakaputaina: (2006)

Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)

Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)

Molecular pathology in drug discovery and development
I whakaputaina: (2009)

Systems biology in drug discovery and development
I whakaputaina: (2011)

Drug utilization research : methods and applications /
I whakaputaina: (2016)

Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)

Collaborative innovation in drug discovery : strategies for public and private partnerships /
I whakaputaina: (2014)

Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)

Life saving drugs the elusive magic bullet /
mā: Mann, J.
I whakaputaina: (2004)

Drug development principles, methodology and emerging challenges /
I whakaputaina: (2013)

Protein and peptide mass spectrometry in drug discovery
I whakaputaina: (2012)

Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)

Applications of transition metal catalysis in drug discovery and development an industrial perspective /
I whakaputaina: (2012)

Classical and adaptive clinical trial designs using ExpDesign Studio [trademark symbol]
mā: Chang, Mark
I whakaputaina: (2008)

Global new drug development : an introduction /
mā: Rosier, Jan A., me ētahi atu.
I whakaputaina: (2014)

Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)

A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)

A comprehensive guide to toxicology in preclinical drug development
I whakaputaina: (2013)

ADME-enabling technologies for drug design and development
I whakaputaina: (2012)

Formulation and analytical development for low-dose oral drug products
I whakaputaina: (2009)

Introduction to biological and small molecule drug research and development theory and case studies /
I whakaputaina: (2013)

Drug metabolism prediction /
I whakaputaina: (2014)

Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)

Statistical issues in drug development
mā: Senn, Stephen
I whakaputaina: (2007)

Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)

Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)

Early drug development strategies and routes to first-in-human trials /
I whakaputaina: (2010)

Drug-membrane interactions analysis, drug distribution, modeling /
mā: Seydel, J. K. (Joachim Karl)
I whakaputaina: (2002)

Structure-based design of drugs and other bioactive molecules : tools and strategies /
mā: Ghosh, Arun K.
I whakaputaina: (2014)

Peptide chemistry and drug design /
I whakaputaina: (2015)